Dosage dependence of the effect of Ginkgo biloba on the rat retinal ganglion cell survival after optic nerve crush

Eye

Volumn 23, Issue 7, 2009, Pages 1598-1604

  Ma, K ^a   Xu, L ^a   Zhan, H ^a   Zhang, S ^a   Pu, M ^a   Jonas, J B ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Flavenoids; Ginkgo biloba; Neuroprotection; Optic nerve crush

Indexed keywords

FLUOROGOLD; GINKGO BILOBA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DENSITY; CELL SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; GINKGO BILOBA; LIPID PEROXIDATION; LOW DRUG DOSE; MALE; NERVE CRUSH; NERVE SHEATH; NONHUMAN; OPTIC NERVE; RAT; RETINA GANGLION CELL;

ADMINISTRATION, ORAL; ANIMALS; CELL SURVIVAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GINKGO BILOBA; NERVE CRUSH; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; RETINAL GANGLION CELLS;

EID: 67749137418     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.286     Document Type: Article

References (31)

1. Congdon N, O'Colmain B, Klaver CC, Klein R, Muñoz B, Friedman DS et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004; 122: 477-485. (Pubitemid 38456282)
2. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120: 1268-1279. (Pubitemid 36105431)
3. Sieving PA, Caruso RC, Tao W, Coleman HR, Thompson DJ, Fullmer KR et al. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci USA 2006; 103: 3896-3901. (Pubitemid 43376652)
4. Müller A, Hauk TG, Fischer D. Astrocyte-derived CNTF switches mature RGCs to a regenerative state following inflammatory stimulation. Brain 2007; 130: 3308-3320. (Pubitemid 350209074)
5. Joly S, Pernet V, Chemtob S, Di Polo A, Lachapelle P. Neuroprotection in the juvenile rat model of light-induced retinopathy: evidence suggesting a role for FGF-2 and CNTF. Invest Ophthalmol Vis Sci 2007; 48: 2311-2320. (Pubitemid 351261311)
6. Wilson RB, Kunchithapautham K, Rohrer B. Paradoxical role of BDNF: BDNF+/- retinas are protected against light damage-mediated stress. Invest Ophthalmol Vis Sci 2007; 48: 2877-2886. (Pubitemid 351261245)
7. Kusari J, Zhou S, Padillo E, Clarke KG, Gil DW. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 2007; 48: 5152-5159. (Pubitemid 351260926)
8. Yücel YH, Gupta N, Zhang Q, Mizisin AP, Kalichman MW, Weinreb RN. Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. Arch Ophthalmol 2006; 124: 217-225. (Pubitemid 43247073)
9. Baudouin C, Ettaiche M, Imbert F, Droy-Lefaix MT, Gastaud P, Lapalus P. Inhibition of preretinal proliferation by free radical scavengers in experimental model of tractional retinal detachment. Exp Eye Res 1994; 59: 697-706.
10. Droy-Lefaix MT, Cluzel J, Menerath JM, Bonhomme B, Doly M. Antioxidant effect of a Ginkgo biloba extract (EGb 761) on the retina. Int J Tissue React 1995; 17: 93-100. (Pubitemid 26046874)
11. Droy-Lefaix MT, Szabo-Tosaki ME, Doly MN. Free radical scavenger properties of EGb 761 on functional disorders induced by experimental diabetic retinopathy. In: Cutler RG, Packe L, Bertram J (eds). Oxidative Stress and Aging. Birkhauser Verlag: Basel, 1996, pp 277-286.
12. Ranchon I, Gorrand JM, Cluzel J, Droy-Lefaix MT, Doly M. Functional protection of photoreceptors from light induced damage by dimethyithiourea and Ginkgo biloba extract. Invest Ophthalmol Vis Sci 1999; 40: 1191-1199. (Pubitemid 29211457)
13. Juárez CP, Muiño JC, Guglielmone H, Sambuelli R, Echenique JR, Hernández M et al. Experimental retinopathy of prematurity: angiostatic inhibition by nimodipine, Ginkgo biloba, and dipyridamole, and response to different growth factors. Eur J Ophthalmol 2000; 10: 51-59. (Pubitemid 30191105)
14. Paasche G, Gärtner U, Germer A, Grosche J, Reichenbach A. Mitochondria of retinal Müller (glial) cells: the effects of aging and of application of free radical scavengers. Ophthalmic Res 2000; 32: 229-236.
15. Ritch R. Potential role for Ginkgo biloba extract in the treatment of glaucoma. Med Hypotheses 2000; 54: 221-235. (Pubitemid 30170967)
16. Cheung ZH, So KF, Lu Q, Yip HK, Wu W, Shan JJ et al. Enhanced survival and regeneration of axotomized retinal ganglion cells by a mixture of herbal extracts. J Neurotrauma 2002; 19: 369-378. (Pubitemid 34246123)
17. Quaranta L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology 2003; 110: 359-362. (Pubitemid 36184342)
18. Hirooka K, Tokuda M, Miyamoto O, Itano T, Baba T, Shiraga F. The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma. Curr Eye Res 2004; 28: 153-157. (Pubitemid 38365818)
19. Hirooka K, Tokuda M, Miyamoto O, Itano T, Baba T, Shiraga F. The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma. Curr Eye Res 2004; 28: 153-157. (Pubitemid 38365818)
20. Xie Z, Wu X, Gong Y, Song Y, Qiu Q, Li C. Intraperitoneal injection of Ginkgo biloba extract enhances antioxidation ability of retina and protects photoreceptors after lightinduced retinal damage in rats. Curr Eye Res 2007; 32: 471-479. (Pubitemid 46789423)
21. Wimpissinger B, Berisha F, Garhoefer G, Polak K, Schmetterer L. Influence of Ginkgo biloba on ocular blood flow. Acta Ophthalmol Scand 2007; 85: 445-449. (Pubitemid 46901492)
22. Cheung ZH, Leung MC, Yip HK, Wu W, Siu FK, So KF. A neuroprotective herbal mixture inhibits caspase-3-independent apoptosis in retinal ganglion cells. Cell Mol Neurobiol 2008; 28: 137-155. (Pubitemid 351251002)
23. Berkelaar M, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci 1994; 14: 4368-4374. (Pubitemid 24200558)
24. Pu M, Berson E. A method for fast and stable intracellular staining of retinal ganglion cells. J Neurosci Methods 1997; 41: 45-49.
25. Levkovitch-Verbin H, Harris-Cerruti C, Groner Y, Wheller LA, Schwartz M, Yoles E. RGC death in mice after optic nerve crush injury: oxidative stress and neuroprotection. Invest Ophthalmol Vis Sci 2000; 41: 4169-4174.
26. Mittag TW, Danias J, Pohorenec G, Yuan HM, Burakgazi E, Chalmers-Redman R et al. Retinal damage after 3-4 months of elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci 2000; 41: 3451-3459. (Pubitemid 30774933)
27. Ma K, Xu L, Wu LQ. Quantitatively analysis of retinal ganglion cells with colour pellet analysis system software. Chn Ophthalmol 2002; 11: 377-379.
28. Allcutt D, Berry M, Sievers JA. A qualitative comparison of the reactions of retinal ganglion cells axons to optic nerve crush in neonatal and adult mice. Develop Brain Res 1984; 16: 231-240. (Pubitemid 15200283)
29. Misantone LJ, Gershenbaum M, Murray M. Viability of retinal ganglion cells after optic nerve crush in adult rats. J Neurocytol 1984; 13: 449-465. (Pubitemid 14094362)
30. Buys YM, Trope GE, Tatton WG. (-)-Deprenyl increases the survival of rat retinal ganglion cells after optic nerve crush. Curr Eye Res 1995; 14: 119-126.
31. Yoles E, Schwartz M. Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve. Arch Ophthalmol 1998; 116: 906-910. (Pubitemid 28554781)